Study objective: To determine the potential value of plasma von Willebrand factor antigenic activity (vWF:Ag) and other commonly measured clinical variables for predicting which patients with precapillary pulmonary hypertension would be unlikely to survive 1 year. Design: Prospective clinical study. The data obtained at the beginning of the study were analyzed at the end of the first year of follow-up. Patients (Tables 1 and 2 ). However, the proportion of pa¬ tients with primary pulmonary hypertension who died in the interval was significantly higher than that for patients with secondary pulmonary hypertension (p < 0.005, Table 1 ). In addition, the nonsurvivors had higher vWF:Ag values at the beginning of the follow-up period than the survivors, and this was highly significant (p < 0.0001, Table 2 
